China's Centralized Procurement Introduces Dynamic Exit Mechanism; Ping An Good Doctor Enhances AI-Powered 'Smart Family Doctor' Service

1. Seven departments, including the Ministry of Industry and Information Technology, jointly issued the "Action Plan for Promoting the Coordinated Development of Large, Medium, and Small Enterprises in the Platform Economy (2026-2028)"

Recently, seven departments—including the Ministry of Industry and Information Technology, the Central Cyberspace Affairs Commission, the National Development and Reform Commission, the Ministry of Science and Technology, the Ministry of Commerce, the State Administration for Market Regulation, and the National Data Administration—jointly issued the “Action Plan for Promoting the Coordinated Development of Large, Medium, Small, and Micro Enterprises in the Platform Economy (2026–2028).” Focusing on three aspects—strengthening innovation-driven coordination, improving the ecosystem coordination system, and deepening open coordination and linkage—the Action Plan outlines key tasks and special initiatives. It launches a coordinated innovation pilot initiative to accelerate the cultivation of diverse innovation entities, promote stronger innovation cooperation among large, medium, small, and micro enterprises, enhance capabilities for technological, industrial, and service-oriented innovation development, improve the support system for innovation-driven development, and inject new momentum into the growth of the platform economy. (Jiemian News)

2、New VBP Rules: Winning Bid No Longer a "Iron Rice Bowl"

Recently,Hainan Provincial Healthcare Security Administration Releases Draft Guidelines on Centralized Procurement of Drugs and Medical Consumables, Clarifying Dynamic Exit Management for Selected SuppliersThe status of being a selected supplier in centralized procurement is no longer an "iron rice bowl." If selected products experience supply disruptions, quality defects, or deterioration in corporate credit that disrupts clinical order due to the enterprise's responsibility, medical institutions may urgently switch brands, and the enterprise’s selected status will be revoked. Previously, in the sixth national centralized procurement of medical consumables, several companies had their qualifications canceled and were suspended from submitting bids due to violations. The dynamic exit mechanism will accelerate industry survival of the fittest, eliminating companies with shortcomings and concentrating market share among compliant players. This institutional design is expected to curb excessive internal competition, ushering centralized procurement into an era of comprehensive capability competition. Future competition will focus on scaled manufacturing, automation levels, and supply chain management. This development benefits leading enterprises with strong capabilities, allowing them to maintain their market share and gain additional growth opportunities. (Sina News)

3. Mabwell and VIVAVISION Reach Strategic Ophthalmology Collaboration

Recently, Mabwell’s subsidiary, Mabwell Vision, has entered into a strategic partnership with VIVAVISION, a company specializing in the research and development of small-molecule ophthalmic drugs. The two parties will focus on unmet clinical needs in the core areas of ocular inflammation and ocular immunity, engaging in comprehensive and in-depth collaboration. Leveraging Mabwell’s pipeline layout and technological accumulation in the ophthalmic field, and VIVAVISION’s professional expertise in small-molecule ophthalmic drug R&D, this cooperation will integrate capabilities in both antibody-based and small-molecule therapeutics to jointly advance the clinical development and commercialization of innovative ophthalmic treatments. (21st Century Business Herald)

4. Baheal Medical’s ZAP-X Radiosurgery Robot Installed at Jinan Cancer Hospital

Recently, Baheal Medical signed a strategic cooperation agreement with Jinan Junxin Cancer Hospital to jointly establish a Precision Radiosurgery Treatment Center centered around the ZAP-X Mars Rover Radiosurgery Robot. This marks the clinical deployment of ZAP-X in the Shandong region, as well as the establishment in Shandong of a radiosurgery platform dedicated to "specialized diagnosis and treatment" for brain tumors and head-and-neck lesions. The ZAP-X system adopts a double-toroidal spherical structure, enabling high-dose focal irradiation of the target area from thousands of non-coplanar angles. By integrating real-time imaging with a dual dose-monitoring system, it achieves sub-millimeter treatment precision. The device has been approved for market launch in 26 countries and regions worldwide, with over 7,500 patients treated to date. Baheal Medical is simultaneously deploying radiosurgery equipment for body and cardiac applications, thereby achieving coverage across multiple disease scenarios. (Qilu Yidian)

5. Ping An Good Doctor Bolsters AI-Powered Physician Services with “Smart Family Doctor”

Recently, Ping An Good Doctor officially upgraded and launched its "Smart Home Doctor" service. Supported by the Ping An YiBoTong large language model as its core technology, the service establishes a model combining "AI second-level response with full-process supervision by human physicians." The system can standardize professional services such as initial symptom screening, condition assessment, medication safety guidance, and health risk assessment, offering 24/7 availability and intelligent responses within three seconds. Meanwhile, a full-process review mechanism by human physicians has been established; all diagnostic and treatment recommendations generated by AI are reviewed and calibrated by licensed practicing physicians, with complex cases automatically triggering transfers to human specialists. Industry observers point out that digitalization, inclusiveness, and scenario-based applications are the core directions for the high-quality development of internet healthcare, with the "AI + Human" dual-engine approach emerging as a new frontier for multi-party exploration. (Cover News)

6. Fourier Rehabilitation Robotics Secures Multi-Million Order in Malaysia

Recently, the Rehabilitation Center of Malaysia’s Social Security Organization (PERKESO) was officially inaugurated, with Fourier Intelligence showcasing its “Intelligent Rehabilitation Port” application solutions and the GR-3 humanoid robot. PERKESO has fully integrated Fourier’s self-developed MetaMotus Galileo Biomechanical Analysis and Training System, providing intelligent rehabilitation services covering assessment, training, and functional recovery for patients with spinal cord injuries, brain injuries, stroke, and other conditions. The two parties have simultaneously established a deep strategic partnership, under which the center will introduce the GRx series of humanoid robots to advance frontier exploration of embodied intelligence in clinical rehabilitation applications. To date, Fourier’s products have obtained 12 international certifications, including US FDA clearance and EU CE MDR certification, serving over 2,000 medical institutions across more than 40 countries and regions worldwide. (White Whale Laboratory)

7. R&D Design Services Accelerate the Clinical Translation of Medical Research Achievements

Medical device R&D is a complex and rigorous process involving technology, regulations, clinical aspects, and more. Osida possesses a 20,000 m² science and technology innovation center and has established a Medical Device Research Institute dedicated to the clinical translation of medical research achievements. It boasts a high-level, international, multidisciplinary team proficient in the entire lifecycle of R&D, regulatory affairs, clinical trials, registration, and manufacturing, capable of developing and producing various complex and innovative products. With extensive project experience and industry resources, Osida has constructed a standardized, regulated, and digitalized end-to-end service system. It provides one-stop services ranging from preliminary market research, product concept generation, and product design and development to prototype production and testing. To date, more than 200 projects have entered the review stage at Osida, with over 100 projects under development, achieving a 100% translation success rate. (Compiled by Osida)

8. Mairun Medical Completes Tens of Millions in Angel and Angel+ Round Financing

Nuoding Xianshi Medical Technology Co., Ltd. recently announced the successful completion of its angel financing round, raising tens of millions of RMB. The round was led by Jiayu Ziniu Medical Fund, a renowned investment institution focused on healthcare and technology, with participation from蒲公英 Fund, Hengqin Hongquan Investment, and several senior industry experts. The funds will accelerate the R&D, clinical trials, and product registration of its AI-driven acoustic energy platform, aiming to pioneer a new professional consumer medicine ecosystem centered on technological innovation. (Dahe Financial Cube)